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bjectives We sought to review our experience with surgical ventricular septal defect (VSD) closure
n adults.
ackground Outcome data of VSD closure in adults on which to base recommendations are lim-
ted. Guidelines recommend closure of adult VSD for a Qp/Qs ratio 2, left ventricular volume over-
oad, or endocarditis.
ethods We retrospectively reviewed 46 patients (mean age 33.6  11.2 years, 24 women) who
nderwent surgical VSD closure (1958 to 2008).
esults VSDs were classiﬁed according to the Society of Thoracic Surgeons as type 2 (membranous,
2%) or type 1 (subarterial, 26%). Aortic regurgitation (AR) (28%), left ventricular dilation (20%), and
ulmonary hypertension (20%) were the most common indications for closure. Associated lesions
ustiﬁed surgery in 39% of patients. There were no early deaths. Morbidity included 1 high-grade
trioventricular block requiring permanent pacemaker and a residual VSD in 7 patients. Late mortal-
ty was 5% (mean follow-up: 10.3  12.4 years). Patient survival did not differ from expected sur-
ival in a reference population (p  0.75). Late residual VSDs were more common after suture clo-
ure (6 of 8 patients). Late moderate AR developed in 5 patients (4 with a type 1 VSD) with aortic
alve or sinus of Valsalva repair. The use of intraoperative transesophageal echocardiography was
ssociated with fewer residual VSDs and less  moderate tricuspid valve regurgitation and AR.
onclusions Associated heart defects and AR were common indications for VSD closure in adults,
hich was performed with low mortality and morbidity. Patch closure and use of intraoperative
ransesophageal echocardiography improve surgical outcomes. Important residua emphasize the
eed for life-long informed follow-up. (J Am Coll Cardiol Intv 2010;3:290–7) © 2010 by the
merican College of Cardiology Foundation
rom the Divisions of *Cardiovascular Diseases and Internal Medicine, †Cardiovascular Surgery, and ‡Biomedical Statistics, Mayo
linic, Rochester, Minnesota. Dr. Mongeon is supported by the Bourse du Coeur 2009 (scholarship) from the Montreal Heart
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291entricular septal defect (VSD) is a very common congen-
tal heart defect in children, but due to spontaneous and
urgical closure, it is less commonly encountered in adults.
tudies have reported the long-term outcome of small
SDs that were not closed during childhood (1–3). About
ne-third of patients with VSD initially managed medically
equired surgical intervention later in life (1).
The outcome of adult patients with an unoperated VSD
s not uniformly favorable. An increased incidence of sudden
eath has been noted regardless of the defect size (1).
ive-year survival without endocarditis or surgery was re-
orted to be 95.5%, with only 3 of 222 patients requiring
urgical closure (3). In a tertiary referral population, Neu-
ayer et al. (2) reported that 25% of patients with small
SDs had serious complications, such as aortic valve regur-
itation (AR) and endocarditis; these were the most com-
on indications for surgical VSD closure in adults, occur-
ing in 10.6% of this series (2).
Current practice guidelines recommend surgical closure
f adult VSDs if there is a left-to-right shunt with a
p/Q s ratio 2 and evidence of left ventricular (LV)
olume overload or associated infective endocarditis (4).
Most surgical series of VSD closure in adults describe the
arlier experience (5,6), making contemporary outcome data
n which to base recommendations very limited (7). We
athered the largest contemporary single center experience
ith surgical VSD closure in adults.
ethods
atient selection. Patients with a VSD who underwent
urgical closure were identified from the Adult Congenital
eart Disease Clinic, Cardiac Surgery, and Echocardiog-
aphy databases at Mayo Clinic. For inclusion, patients had
o be 18 years of age or older at the time of surgical VSD
losure done at Mayo Clinic in Rochester, Minnesota. The
xclusion criteria were the presence of any of the following:
) a double inlet or double outlet ventricle; 2) transposition of
he great arteries; 3) atresia of any valve; 4) a conotruncal
bnormality; 5) an atrioventricular septal defect; or 6) Ebstein
nomaly. The protocol was approved by the Mayo Clinic
nstitutional Review Board.
Three hundred eighty-nine patients were identified
mong which 343 were excluded because they met exclusion
riteria or did not undergo VSD closure as part of their
peration. The remaining 46 patients formed the study
roup.
ata collection. We used the Society of Thoracic Surgeons
STS) classification of VSDs (8) as proposed in national
ractice guidelines (4). Conal, subpulmonary, infundibular,
upracristal, and doubly committed juxta-arterial defects are
rouped under STS type 1 VSDs. Perimembranous,
aramembranous, and conoventricular defects form the STS
ype 2. The STS type 3 VSDs include inlet and atrioven- uricular canal varieties, and muscular VSDs are designated as
TS type 4 (4). Details regarding past medical and surgical
istory, intracardiac hemodynamics, ventricular function,
ssociated cardiac anomalies, pre- and post-operative
arnes-Somerville ability index (9) and New York Heart
ssociation functional class, surgical indication, and both
arly and late outcomes were abstracted from a retrospective
eview of clinical notes, surgical protocols, and imaging
tudy reports.
Follow-up started on the day of surgery. The early
ost-operative period was defined as 30 days after surgery or
s the surgical hospitalization, whichever was longer.
ollow-up ended on the latest date at which the patient’s
ital status could be ascertained. All pre-operative evalua-
ions were performed by the patients’ personal physicians at
ayo Clinic. Follow-up clinical evaluations and imaging
tudies performed at Mayo Clinic were reviewed, external
linical documents on file at Mayo Clinic were reviewed
hen Mayo Clinic evaluation
as not performed.
urgery. Standard techniques
or cardiopulmonary bypass were
sed. Cold potassium, blood
ardioplegic solution has been
sed for myocardial protection
ince 1977. The use of suture or
atch closing technique and the
pproach to the ventricular sep-
um were noted.
The largest VSD diameter or
he diameter of the largest defect
t surgical inspection was used as
he gold standard for assessment
f defect size. When a VSD
iameter was not reported in the
urgical note, the diameter re-
orted in pre-operative imaging studies was used.
chocardiography. Use of state-of-the-art equipment and
rotocols (10,11) could be ensured for the majority of
omprehensive 2-dimensional and Doppler echocardio-
rams. Data were abstracted from clinical reports.
The LV size and ejection fraction were assessed with
-dimensional echocardiographic guidance (12), by visual
stimate (13), or using the Simpson biplane method (14).
ricuspid valve regurgitation (TR) and AR were assessed
emiquantitatively as absent, trivial, mild, moderate,
oderate-to-severe, and severe. Tricuspid regurgitant jet
ystolic velocity by continuous wave Doppler was used to
stimate the right ventricular systolic pressure (15). The
iameter of the VSD was measured on 2-dimensional
maging. The peak flow velocity through the VSD was
easured by continuous wave Doppler.
atheterization. Hemodynamic calculations were verified
Abbreviations
and Acronyms





LV  left ventricle
LVEF  left ventricular
ejection fraction
STS  Society of Thoracic
Surgeons
TR  tricuspid valve
regurgitation
VSD  ventricular septal
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292ion performed at Mayo Clinic or at referring institutions
hen a recent study was performed there.
tatistical analysis. Descriptive statistics for categorical vari-
bles are reported as frequency and percentage whereas
ontinuous variables are reported as mean and standard
eviation. Kaplan-Meier method was used to estimate the
urvival rate at 5, 10, and 15 years. Log-rank test was used
o compare the survival of our patient group to the Minne-
ota white population. All statistical tests were 2-sided with
he alpha level set at 0.05 for statistical significance.
esults
aseline characteristics. The baseline characteristics of our
tudy population are presented in Table 1. Most of the
atients were 30 years of age or younger at the time of
urgery. The oldest patient was 64 years of age. The STS
ype 2 VSDs were the most common. Five patients (11%)
resented with a residual VSD after attempted closure, and
patient had multiple septal defects. The pre-operative
unctional class was good in most patients.
The VSD diameter was measured at time of surgery in 37
atients. An echocardiography-derived VSD diameter was
Table 1. Baseline Characteristics (n  46)
Age at surgery, yrs 33.6 11.2
Female sex 24 (52)
Society of Thoracic Surgeons type of VSD
Type 1 (subarterial) 12 (26)
Type 2 (membranous) 33 (72)
Type 3 (inlet) 1 (2)
Type 4 (muscular) 0
VSD diameter, mm 11.4 10.5
Associated lesions
Coronary cusp prolapse 15 (33)
With sinus of Valsalva aneurysm 5 (11)
Patent foramen ovale 7 (15)
Bicuspid aortic valve 6 (13)
Mitral regurgitation 6 (13)
Right ventricular outﬂow tract obstruction 6 (13)
Atrial septal defect 5 (11)
First degree atrioventricular block 3 (7)
Patent ductus arteriosus 3 (7)
Persistent left superior vena cava 3 (7)









Data are n (%) or mean SD.iVSD ventricular septal defect.sed in 4 patients, and 5 had no measure of the defect
iameter. One-half of the patients had a VSD diameter
maller than 7 mm. The largest VSD was a 50-mm STS
ype 2 defect in a patient who had associated right ventric-
lar outflow tract obstruction due to previous pulmonary
rtery banding.
Associated cardiac lesions are presented in Table 1. A
inus of Valsalva aneurysm without cusp prolapse was
resent in 2 patients. Peripheral pulmonary stenosis, double
hamber right ventricle, pulmonary valve regurgitation,
ubaortic stenosis, valvular aortic stenosis, an aneurysm of
he ascending aorta, and mitral valve prolapse were each
resent in 1 patient.
re-operative echocardiographic and catheterization data.
pre-operative echocardiogram was available in 42 patients
nd a pre-operative catheterization was available in 21
atients (Table 2). The LV was enlarged in the majority of
atients (mean LV end-diastolic diameter 55 mm, range 39
o 79 mm). The systolic function was preserved or mildly
mpaired (LV ejection fraction [EF] range 42% to 74%).
ny degree of AR and TR were present in 24 (69%) and in
2 (94%) patients, respectively. There was no clustering of
R or TR according to the VSD type. The peak velocity of
ow across the VSD was reported in 23 patients. It was high
mean 4.9  0.7 m/s, range 3.3 to 6.7 m/s) suggesting that
ost defects were restrictive. Right ventricular and pulmo-
ary artery pressures and resistance were moderately ele-
ated. A selection bias may exist with the patients most
ikely to have pulmonary hypertension or those in whom
oninvasive assessment of pulmonary pressures was not
ossible being submitted to catheterization.
ndications for VSD closure. The surgical indications for
SD closure are listed in Table 3 in decreasing order of
requency. Coexisting congenital or acquired structural
eart lesions were the primary motivation for surgical repair
Table 2. Pre-Operative Echocardiographic and Catheterization Data
Echocardiography
Left ventricular end-diastolic diameter, mm 39 55 8
LVEF, % 42 61 7
Tricuspid regurgitation peak velocity, m/s* 26 2.81 0.46
Tricuspid regurgitation  moderate 34 6 (18)
Aortic regurgitation  moderate 35 6 (17)
Catheterization
Qp/Qs 19 1.6 0.5
Left ventricular end-diastolic pressure, mm Hg 16 12 3
Right ventricular systolic pressure, mm Hg* 20 50 27
Mean pulmonary artery pressure, mm Hg 20 25 16
Pulmonary vascular resistance index, WU · m2 18 5.6 4.5
Data are n (number of patients for which the data were available), n (%), or mean SD. *Patients
with right ventricular outflow tract obstruction and double chamber right ventricle were ex-
cluded from the analysis of this parameter.
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293he following conditions in 4 patients: cyanosis due to a
arge VSD with an obstructive pulmonary artery band, large
trial septal defect, severe aortic stenosis, and severe coarc-
ation of the aorta. To be allowed to serve in the military, 1
atient requested a VSD closure.
urgical data. The earliest surgery was done in 1958, but
ost were performed after 1980 (Fig. 1). Suture closure was
sed in 22 patients (48%) (Table 4). Nearly all of them (18
f 22) had a VSD diameter 10 mm or described as small.
he most common approach for VSDs was from the atria.
n LV approach was never required. A majority of patients
74%) underwent concomitant repair of other cardiac
efects.
Tricuspid valve repair was performed in 11 patients (24%)
Table 4) because of tricuspid tissue obstructing the VSD.
re-operative severe TR was uncommon (6%). The tricus-
id valve was repaired in 4 patients with mild or less TR
Fig. 2).
Figure 1. Distribution of Surgical VSD Closures at Mayo Clinic
Distribution of surgical ventricular septal defect (VSD) closures per decade
Table 3. Indications for Surgery
Aortic regurgitation 13 (28)
Left ventricular dilation 13 (28)
Pulmonary hypertension 9 (20)
Endocarditis 8 (17)
Symptoms 6 (13)
Left ventricular dysfunction 4 (9)
Sinus of Valsalva aneurysm 5 (11)
Ruptured 3 (7)
Not ruptured 2 (4)
Coronary cusp prolapse 3 (7)
Double chamber right ventricle 3 (7)
Mitral regurgitation 3 (7)
Qp/Qs 2 3 (7)
Subaortic stenosis 1 (2)
Data are n (%). Total is100% because many patients had multiple indications.p
at Mayo Clinic. Only 4 patients were operated before 1980.Aortic valve or sinus of Valsalva repair were performed in
2 patients (26%) (Table 4). Among them, 6 patients had
ild or less AR pre-operatively (Fig. 2); in 3 patients, a
uptured sinus of Valsalva aneurysm justified surgery. Of the
emaining 3 patients, 2 had cusp prolapse.
In addition, 2 patients had surgical enlargement of the
ight ventricular outflow tract; 2 had closure of a patent
uctus arteriosus; and pulmonary valvotomy, resection of
ubaortic stenosis, Maze procedure, resection of a membra-
ous septal aneurysm, repair of coarctation of the aorta and
V myectomy, ligation of a left superior vena cava, and an
scending aortoplasty were performed in 1 patient each.
utcomes. There was no operative mortality. Post-
perative atrial fibrillation occurred in 9% of patients. There
as 1 case of high-grade atrioventricular block requiring
arly post-operative permanent pacing. Significant pleural
nd pericardial effusions occurred in 3 patients and 1 had
ardiac tamponade 2 months after surgery. Post-operative
orbidity also included hemorrhage (not leading to reop-
ration), thrombophlebitis, retained temporary pacemaker
ire, and an episode of unexplained fever and abdominal
ain, occurring in 1 patient each. Among 40 patients with
n early post-operative echocardiogram, the mean LV
nd-diastolic diameter and LVEF were 50  8 mm and
5  9%, respectively.
Follow-up beyond hospital dismissal, available in 40
Table 4. Surgical Data (n  46)
Prior cardiac surgery 8 (17)
Prior ventricular septal defect closure 5 (11)
Type of closure
Primary closure 22 (48)





Unspeciﬁed patch 2 (4)
Surgical approach
Transatrial 23 (50)
Right ventricular 16 (35)
Aorta 4 (9)
Pulmonary artery 2 (4)
Concomitant procedures 34 (74)
Aortic valve or sinus of Valsalva repair 12 (26)
Tricuspid valve repair 11 (24)
Atrial septal defect closure 9 (20)
Resection of right ventricular or subpulmonary diaphragm 4 (9)
Mitral valve repair 4 (9)
Aortic valve replacement 3 (7)
Cardiopulmonary bypass time, min 84 42
Aortic cross clamp time, min 52 29
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294late post-operative echocardiogram was available for 34
atients. Only 3 late studies were performed outside Mayo
linic. Late mortality was low (5%) (Table 5). Survival rates
t 5, 10, and 15 years after surgery were 100%, 95%, and
8%, respectively, and did not differ significantly from
xpected survival rates (p  0.75) (Fig. 3). Patients had a
ood functional status (Table 5). The cause of the 2 late
eaths in our cohort could not be identified. We found no
ecord of sudden cardiac death. One patient (3%) had
ocumented nonsustained ventricular tachycardia and 10%
f patients developed atrial fibrillation at late follow-up.
ne patient underwent 2 reoperations: a residual VSD was
losed 42 years after the initial surgery, along with coronary
rtery bypass grafting and 2 successive aortic valve replace-
Figure 2. Outcomes of Valve Repair at Time of Surgical VSD Closure
Outcomes of valve repair at the time of surgical ventricular septal defect
(VSD) closure. (A) Aortic valve regurgitation (AR) before and after aortic
valve or sinus of Valsalva repair in 12 patients (7 Society of Thoracic Sur-
geons [STS] type 1 VSDs and 5 STS type 2 VSDs). (B) Tricuspid valve regur-
gitation (TR) before and after tricuspid valve repair in 11 patients, all with a
STS type 2 VSDs. Preop  pre-operative; postop  post-operative.ents. One patient had atrioventricular node ablation andacemaker implantation 8 months after surgery for persis-
ent atrial arrhythmias.
Among the 7 residual VSDs (18% of patients) identified
n the post-operative period, 6 were described as small; size
as not reported for 1 VSD identified with dye curves.
mong the 8 residual VSDs (23% of patients) identified at
ate follow-up, 7 were small and 1 was of moderate size. It
s noteworthy that suture closure was used in 6 of 8 patients
ith a residual VSD at late follow-up. Echocardiographic
creening for a residual VSD was performed in 87% of
Figure 3. Survival After Surgical VSD Closure Versus
Reference Population
Survival after surgical ventricular septal defect (VSD) closure compared with
a reference population. There was no difference in 15-year survival of oper-
Table 5. Late Outcomes After Surgical VSD Closure
Follow-up, yrs 40 10.3 12.4
Mortality 40 2 (5)
Warnes-Somerville ability index 1–2 37 37 (100)
New York Heart Association functional class I–II 37 36 (97)
High-grade atrioventricular block 34 0
Permanent pacemaker 35 3 (9)
Ventricular tachycardia 40 1 (3)
Atrial ﬁbrillation 40 4 (10)
Atrial ﬂutter 40 2 (5)
Supraventricular tachycardia 40 4 (10)
Residual VSD 35 8 (23)
Reoperation 40 2 (5)
Echocardiogram at latest follow-up
Time after surgery, yrs 34 9.7 12.9
Left ventricular end-diastolic diameter, mm 33 52 6
LVEF, % 32 57 8
Tricuspid regurgitation peak velocity, m/s 28 2.66 0.48
Tricuspid regurgitation  moderate 28 6 (21)
Aortic regurgitation  moderate 30 5 (17)
Data are n (number of patients for which the data were available), n (%), or mean SD.
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295atients post-operatively and in 74% of patients at late
ollow-up.
Some degree of TR was present in 33 of 34 patients
97%) and in all patients in whom it was assessed by
chocardiography at early and late follow-up, respectively.
ricuspid valve regurgitation was moderate or greater in 5
atients (15%) early after surgery. Among the 6 patients
ith more than moderate TR at late follow-up, 5 had an
TS type 2 VSD, 3 had a tricuspid valve repair, 3 had a
esidual VSD, 2 had pre-operative right ventricular outflow
ract obstruction, 2 had a late TR velocity 2.5 m/s, and 1
ad the VSD closed with a patch. Moderate or greater TR
t late follow-up was present in 27% of patients (3 of 11)
ho had a tricuspid valve repair (Fig. 2).
Aortic valve regurgitation was present in 22 of 32 patients
69%) and in 23 of 30 patients (82%) with early and late
chocardiographic follow-up, respectively. At early follow-
p, all cases of AR were mild or less. The AR became
oderate in 5 patients (17%) at late follow-up. Among
hese patients, all underwent aortic valve or sinus of Valsalva
epair at the time of VSD closure, 4 had an STS type 1
SD, and 3 developed an aneurysm of the proximal aorta
uring follow-up. Among patients who had aortic valve or
inus of Valsalva repair, AR decreased in 5 patients, in-
reased in 2 patients, and did not change in 3 (unknown AR
tatus in 2 patients) during follow-up (Fig. 2). The preva-
ence of moderate late AR after aortic valve repair was 42%.
OTEE. Intraoperative transesophageal echocardiography
IOTEE) was used in 38 patients (82.6%). An early and a
ate residual VSD were present in 6 patients (15.8%) and in
patients (10.5%) who had an IOTEE compared with 1
atient (12.5%) and 4 patients (50.0%) who did not have an
OTEE. Moderate or more AR (n  2, 25.0%) and TR
n  2, 25.0%) at late follow-up were more common in
atients who did not have an IOTEE. In patients who had
n IOTEE, late  moderate AR was present in 3 patients
7.9%) and late  moderate TR was present in 4 patients
10.5%).
arly surgical experience. We identified 4 patients operated
n between 1950 and 1980. The only meaningful difference
n late outcomes is the presence of a residual VSD in 3
atients (75%) compared with 5 patients (12%) in the 1980
o 2008 group.
iscussion
ummary of results. We report the largest contemporary
91% of patients operated after 1980) series of adults who
nderwent surgical VSD closure at a single institution. The
TS type 2 VSDs (membranous) were the most common.
evere TR and AR were uncommon.
The most common surgical indications were AR, LV
ilation, and pulmonary hypertension. Patch closure and a
ransatrial approach were most frequently used. Suture ilosure was most commonly used in patients with a residual
SD, which was present in 18% of patients post-operatively
nd in 24% at late follow-up.
There were no perioperative deaths. Late mortality was
%. Survival at 15 years was not different from the expected
urvival in a reference population. There was a low inci-
ence of ventricular arrhythmias. The use of IOTEE was
ssociated with fewer residual VSDs and less late  mod-
rate AR and TR.
ndications. Most surgical indications were consistent with
revious series (2,6,7). Moderate pulmonary hypertension
as the only indication for VSD closure in 2 patients and
actored in the decision for surgery in 8 patients. These
atients’ VSDs measured 4 to 20 mm and 7 of the 8 patients
id not have another lesion to account for the pulmonary
ypertension. One patient had moderate-to-severe mitral
egurgitation. Otterstad et al. (6) mentioned pulmonary
ypertension among their surgical indications for medium
nd large VSDs only. It is, however, known that small
SDs can also be associated with pulmonary hypertension
1,16). Numerous congenital heart defects were present in
ur patients (Table 1). A bicuspid aortic valve was present in
3% of patients, an association already reported by Neu-
ayer et al. (2). Although some of the coexisting lesions
rompting operative repair were independent from the
SD, coronary cusp prolapse, often complicated by aneu-
ysm of the sinus of Valsalva and always associated with AR,
as the most common (n  8). The AR was mild or less in
of 8 patients and 3 patients had a ruptured aneurysm.
hese observations suggest that associated heart defects are
s important as the hemodynamic consequences of the VSD
n deciding to perform surgical repair.
arly mortality. The absence of operative mortality in our
eries differs from the 6% reported by Kidd et al. (1) but is
imilar to another adult series (7). Most surgeries in our
ohort were performed during the last 2 or 3 decades on
atients in good pre-operative condition. Other adult VSD
losure series reflect the earlier experience and report oper-
tive mortalities of 4.7% and 9.8% (5,6).
ate mortality. Mortality at a mean follow-up of 10 years
as low in our series, similar to other reports (5–7) but
ower than the late mortality (11% [55 of 483] of patients)
f the surgically managed patients in the NHS-2 (Second
atural History Study) trial (1).
rrhythmias. The low prevalence of ventricular arrhythmias
t follow-up potentially explains the low mortality in our
ohort. The previously reported incidences of sudden death
39% of all deaths) and serious arrhythmias (ventricular
achycardia 14.8%) in VSD patients, especially those treated
urgically, were substantially higher (1,16). We cannot
peculate on the influence of a ventricular or atrial approach
n late survival because numerous patients in our cohort had
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296ad an atriotomy and also had a large atrial septal defect
ith right ventricular volume overload. Echocardiographic
ollow-up was not available for this patient.
The common use of an atriotomy and the presence of
arious structural heart diseases may explain that atrial
rrhythmias occurred in 23% of patients at follow-up. Atrial
brillation (10%) was the most common atrial arrhythmia
nd was more common than in previous reports of surgically
7) and medically (2) managed VSD patients.
Atrioventricular block was uncommon and permanent pac-
ng was rarely required in our series as well as in others (6).
esidual VSD. The prevalence of a residual VSD was 19.5%
n the NHS-2 study (1), but reached 34% in other series (6).
e did not find that residual VSDs were related to the early
urgical experience, as previously reported (6). On the
ontrary, better imaging may have allowed better detection
n recent years. Most defects were small and hemodynam-
cally insignificant. Only 1 patient underwent closure of the
esidual defect and it was not the primary indication for the
urgery. However, 11% of patients presented to us with a
esidual VSD requiring closure. Surgical indications were
ulmonary hypertension in 4 patients, mitral regurgitation
n 2 patients, and symptoms in 1 patient. The Q p/Q s ratio
as above 2 to 1 in 1 patient who had a 40-mm defect. The
thers had defects between 5 and 10 mm, but 3 of them had
n elevated pulmonary artery pressure or pulmonary vascular
esistance. Of interest, a majority of our patients with a
esidual VSD at late follow-up had suture closure of the
SD between 1964 and 2007. This finding thus supports
he use of patch closure. Late residual VSDs were less
ommon in patients who had an IOTEE, supporting its
outine use.
alvular regurgitation and valve repair. The prevalence of
R (82%) was higher in our patients at follow-up than in
ol Raap et al. (7) series but similar to Otterstad et al. (6)
eries. A higher prevalence of STS type 1 VSDs in our series
26%) may explain this finding. Other potential associations
ith moderate or more AR at late follow-up include aortic
alve or sinus of Valsalva repair, a dilated proximal aorta at
ollow-up, and lack of use of IOTEE. No patient had a
esidual VSD or a bicuspid aortic valve. Our limited data do
ot suggest that the severity of pre-operative AR, the
losure technique, and the VSD size predict failure of the
epair and development of moderate AR at follow-up, as
ound in larger series (17,18). In their study, van Son et al.
19) identified the presence of a subarterial VSD and a sinus
f Valsalva to right ventricle shunt as risk factors for AR
fter repair of a ruptured sinus of Valsalva aneurysm.
TR was almost universal. Potential associations with
ore-than-moderate late TR include an STS type 2 VSD,
he presence of a residual VSD, previous tricuspid valve
epair, and lack of use of IOTEE. We observe no relation of
oderate or more severe TR with the use of a patch for
SD closure. Peak TR velocities in patients with greater- than-moderate late TR were between 2.5 and 3.7 m/s.
ricuspid valve repair (11 patients) was performed exclu-
ively in patients with a STS type 2 VSD. At late follow-up,
R decreased from severe to moderate in 2 patients;
owever, it progressed from moderate to severe in 1 patient
espite repair. Late TR velocity, closure technique, and the
resence of a residual VSD are not associated with failure of
ricuspid valve repair in our series.
entricular size and function. The mean LV end-diastolic
iameter at late follow-up in our cohort is within normal
imits in adults (54 mm) (14) as reported in a similar series
7). The mean early and late post-operative LVEF in our
ohort are near normal and comparable to previous reports
7,20). In patients who had a VSD closed in childhood,
VEF is lower when compared with control subjects (20)
nd fractional shortening is abnormal in 22% (21). Potential
auses of ventricular dysfunction after VSD closure include
ess advanced myocardial protection during the early surgi-
al experience and long-standing volume loading when the
efect is repaired as an adult (16,20).
tudy limitations. Our study is retrospective and limited to
tertiary care center with expertise in adult congenital
ardiology and surgery. Thus, our results may not be directly
pplicable to all practices. Follow-up after the surgical
ospitalization was unavailable in 15% of patients. As it is
he case in other series (5), heterogeneity is introduced in
ur study population by the fact that concomitant congen-
tal or acquired structural heart lesions were the primary
otivation for consideration of repair in 18 patients (39%).
ost patients did not have 24-h Holter monitoring per-
ormed during follow-up, thus the occurrence of arrhyth-
ias may be underestimated. Despite our best efforts, we
annot exclude that the 2 patients who died during late
ollow-up suffered sudden cardiac death. There were few
atients who did not have IOTEE guidance during VSD
losure, which limits the assessment of its incremental value.
atients operated on before major progress in cardiac
urgery, such as cold potassium blood cardioplegia, are also
nder-represented, limiting meaningful comparisons be-
ween our early and contemporary experience.
linical implications. In our practice, common indications
or VSD closure included AR, pulmonary hypertension, and
ssociated defects, especially aortic valve cusp prolapse. This
s in contrast to practice guidelines (4) that emphasize LV
olume overload. Surgical closure of a VSD in adults can be
ccomplished with very low short- and long-term mortality
nd morbidity. Clinically significant ventricular arrhythmias
ere less prevalent in our series than previously reported and
trial fibrillation was more common. Aortic and tricuspid
alve regurgitation were very common at follow-up. Signif-
cant AR occurred predominantly in patients who had
losure of an STS type 1 VSD and repair of the aortic valve
r sinus of Valsalva. The VSD patch closure appears to be
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297ore often after suture closure. We support the routine use
f IOTEE guidance because it may lead to less late AR, TR,
nd residual VSDs. These data emphasize important residua
nd the need for life-long informed cardiology follow-up.
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